Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-06-23 Biller Scott Chief Scientific Officer Grant or award · Stock option (right to buy) +12,363 314,880
2015-06-18 NELSEN ROBERT Director Other disposition −386,074 1,630,368
2015-06-18 NELSEN ROBERT Director Other acquisition +19,622 47,666
2015-06-17 NELSEN ROBERT Director Other disposition −386,074 2,016,442
2015-06-17 NELSEN ROBERT Director Other acquisition +19,622 28,044
2015-06-16 Biller Scott Chief Scientific Officer Exercise or conversion +300 $0.47 $140 37,570
2015-06-16 Biller Scott Chief Scientific Officer Exercise or conversion · Stock option (right to buy) −300 302,517
2015-06-15 MARAGANORE JOHN Director Gift −410 49,764
2015-06-15 Higgons John Duncan Chief Operating Officer Sale −7,000 $105.23 $737K 121,835
2015-06-12 Higgons John Duncan Chief Operating Officer Exercise or conversion +10,000 $0.30 $3K 128,835
2015-06-12 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −10,000 335,022
2015-06-11 Higgons John Duncan Chief Operating Officer Exercise or conversion +10,000 $0.30 $3K 118,835
2015-06-11 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −10,000 345,022
2015-06-10 Higgons John Duncan Chief Operating Officer Exercise or conversion +10,000 $0.30 $3K 108,835
2015-06-10 Higgons John Duncan Chief Operating Officer Exercise or conversion · Stock option (right to buy) −10,000 355,022
2015-06-08 Biller Scott Chief Scientific Officer Sale −5,500 $121.85 $670K 37,270
2015-06-01 Schenkein David P Chief Executive Officer Sale −6,500 $120.67 $784K 79,082
2015-06-01 Schenkein David P Chief Executive Officer Sale −6,500 $120.67 $784K 232,272
2015-06-01 Bowden Christopher Chief Medical Officer Exercise or conversion +5,000 $35.16 $176K 5,000
2015-06-01 Bowden Christopher Chief Medical Officer Sale −5,000 $120.67 $603K 0

Page 90 of 93 · 1,853 trades